Overview

A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

Status:
RECRUITING
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
This study is being conducted to characterize the efficacy and safety of nirogacestat in Japanese adults with progressing desmoid tumors/aggressive fibromatosis.
Phase:
PHASE2
Details
Lead Sponsor:
SpringWorks Therapeutics, Inc.
Treatments:
nirogacestat